Quantcast

FDA Says Yaz Labels Should Be Rewritten for Risk of Blood Clots

Yaz Risk of Blood Clots The newer generation birth control pills, which include Yaz, Yasmin, Beyaz, and Sayfral, may soon be slapped with a new warning label that says the products are more likely to cause blood clots than other forms of oral contraceptives. In a 21 to 5 vote on Thursday, the U.S. Food and Drug Administration concluded that the labels on these contraceptives don’t adequately warn patients and do not accurately portray the risk-benefit ratio of the drug. The pills contain the hormone drospirenone, also used for the … [Read more...]

Yaz Birth Control Lawsuits Continue

Yaz Birth Control Lawyers Yaz birth control is being cited by a distraught mother who  is suing the  drug maker for her daughter"s death which allegedly resulted  from a fatal blod clot she received after taking the birth control pill, Yaz. , the 18-year-old a freshman at Elon University in North Carolina, collapsed on her way to class last September.  The autopsy discovered that she had a fatal blood clot that lodged in her lung and caused her to suffer a heart attack. Her mother says she believes that her daughter would be alive today if she … [Read more...]

Yaz Birth Control Claims Continue

A distraught mother is suing the maker of Yaz birth control claiming her daughter died from a fatal blod clot she received after taking the birth control pill. , the 18-year-old a freshman at Elon University in North Carolina, collapsed on her way to class last September.  The autopsy discovered that she had a fatal blood clot that lodged in her lung and caused her to suffer a heart attack. Her mother says she believes that her daughter would be alive today if she had not been taking the birth control pill Yaz.  She said that the prescription … [Read more...]

Bayer's Damage Control for Yaz

One of the most popular oral contraception pills in the U.S. market is Yaz, with reported sales of $616 million in 2007 alone. The active ingredients of the drug is estrogen and progestin and is considered a low dose pill as it contains only 0.035 milligrams or less of estrogen. The drug received FDA approval in March 2006 primarily as an oral contraceptive and then in March 2009 as a treatment for premenstrual dysphoric disorder or PMDD. It was also approved as a treatment for moderate acne in January 2007. As the years passed, evidence has … [Read more...]